ASIA unversity:Item 310904400/4631
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 94286/110023 (86%)
造访人次 : 21696509      在线人数 : 887
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/4631


    题名: Crossregulation of NF-KB by the APC/GSK-3beta/beta-catenin pathway
    作者: Deng, J.;Xia, W.;Miller, S. A.;Wen, Y.;Wang, H.;Mien-Chie Hung
    关键词: APC;GSK-3;-catenin;NF-B;breast cancer
    日期: 2004-03
    上传时间: 2009-11-27 05:57:09 (UTC+0)
    出版者: Asia University
    摘要: Glycogen synthase kinase-3 (GSK-3) and adenomatous polyposis coli (APC) play an important role in the regulation of -catenin. Inhibition of or defects in their functions can lead to activation of -catenin. -catenin has been recently found to interact with and inhibit nuclear factor kappa B (NF-B). However, the regulatory roles of GSK-3/APC on the NF-B signaling pathway are unknown because of their diverse effects. In this study, we investigated whether GSK-3/APC might regulate NF-B activity through -catenin. We found that inhibition of GSK-3 suppressed NF-B activity, whereas reexpression of APC restored NF-B activity in APC mutated cells. The regulatory effects were through -catenin because depletion of -catenin with small interfering RNA (siRNA) in the same systems reversed the effects. The regulatory relationship was further supported by the analysis of primary breast tumor tissues in vivo in which NF-B target TRAF1 was inversely correlated with activated -catenin. Thus, APC/GSK-3, through -catenin, may crossregulate NF-B signaling pathway.
    關聯: MOLECULAR CARCINOGENESIS 39(3):139-146
    显示于类别:[生物科技學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    0KbUnknown709检视/开启
    310904400-4631 .doc30KbMicrosoft Word427检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈